Biologic treatments for elderly patients with psoriasis.

about

Managing Mild-to-Moderate Psoriasis in Elderly Patients: Role of Topical Treatments.Autoimmunity and autoimmune co-morbidities in psoriasis.Advances in treating psoriasis in the elderly with small molecule inhibitors.

P2860

Q40114903-48401781-BF65-4B51-9AEF-709B7A4F60BB Q48283379-CDE18CD3-95E2-47DE-B8D7-A6DD57785991 Q49679446-9F6453A6-B471-4710-A229-284F73A6D6A2

P2860

Biologic treatments for elderly patients with psoriasis.

Item

http://www.wikidata.org/entity/Q48236525

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Biologic treatments for elderly patients with psoriasis.

@en

Biologic treatments for elderly patients with psoriasis.

@nl

type

Item

label

Biologic treatments for elderly patients with psoriasis.

@en

Biologic treatments for elderly patients with psoriasis.

@nl

prefLabel

Biologic treatments for elderly patients with psoriasis.

@en

Biologic treatments for elderly patients with psoriasis.

@nl

P1476

Biologic treatments for elderly patients with psoriasis

@en

P2093

Akihiko Asahina

http://www.w3.org/2001/XMLSchema#string

Hidemi Nakagawa

http://www.w3.org/2001/XMLSchema#string

Mitsuha Hayashi

http://www.w3.org/2001/XMLSchema#string

Yoshinori Umezawa

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database.

Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis.

Pathogenesis and clinical features of psoriasis.

Adverse effects of corticosteroids: I. Topical and intralesional.

Ustekinumab associated with flares of psoriatic arthritis.

The safety of anti-TNF agents in the elderly.

Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients.

Hepatitis B virus reactivation after ustekinumab treatment: reply from authors.

Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients.

The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection.

P304

1020-1023

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1346-8138.13853

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Koichi Yanaba

Mami Momose

P577

2017-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28439956

http://www.w3.org/2001/XMLSchema#string

Biologic treatments for elderly patients with psoriasis.

about

P2860

P2860

Biologic treatments for elderly patients with psoriasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698